World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
81
Citations
20614
World Ranking
1111
National Ranking
31

Medicine

D-Index
81
Citations
20922
World Ranking
16780
National Ranking
251

Sabine Yerly publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Sabine Yerly sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 325 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Sabine Yerly D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Sabine Yerly sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 81 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Sabine Yerly is affiliated with the University of Geneva in Switzerland and has contributed extensively to research in the field of medicine, particularly focusing on infectious diseases. Their work encompasses subfields such as infectious diseases, virology, epidemiology, emergency medicine, and hepatology.

Their research topics cover a range of areas within infectious diseases, with particular emphasis on HIV research and treatment, SARS-CoV-2 and COVID-19 research, and HIV/AIDS interventions. Specific areas of focus include:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS drug development and treatment
  • COVID-19 Clinical Research Studies
  • HIV-related health complications and treatments
  • SARS-CoV-2 detection and testing

Yerly has published in several known venues related to infectious diseases and microbiology. Frequent publication venues include:

  • Clinical Infectious Diseases
  • The Journal of Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Open Forum Infectious Diseases
  • Journal of Antimicrobial Chemotherapy

Recent papers authored or co-authored by Yerly include:

  • Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study, 2020, The Lancet
  • Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland, 2020, The Lancet Infectious Diseases
  • Validation of a commercially available SARS-CoV-2 serological immunoassay, 2020, Clinical Microbiology and Infection
  • Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study, 2021, Clinical Microbiology and Infection
  • Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT), 2020, Emerging Microbes & Infections

Collaborations form an important part of Yerly's research. Frequent co-authors include:

  • Huldrych F. Günthard
  • Enos Bernasconi
  • Matthias Cavassini
  • Laurent Kaiser
  • Alexandra Calmy

Best Publications

  • Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.

    Silvia Stringhini;Silvia Stringhini;Silvia Stringhini;Ania Wisniak;Giovanni Piumatti;Giovanni Piumatti;Andrew S Azman;Andrew S Azman

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • Transmission of antiretroviral-drug-resistant HIV-1 variants

    S Yerly;L Kaiser;E Race;J P Bru

  • Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

    Selidji T Agnandji;Angela Huttner;Madeleine E Zinser;Patricia Njuguna

  • Cohort profile: the Swiss HIV Cohort study

    Franziska Schoeni-Affolter;Bruno Ledergerber;Martin Rickenbach;Christoph Rudin

  • The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan

    Victor DeGruttola;Lynn Dix;Richard D'Aquila;Dan Holder

  • Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen

    Nicolas Sachsenberg;Alan S. Perelson;Sabine Yerly;Gérard A. Schockmel

  • Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

    Ravindra K Gupta;Andrew Hill;Anthony W Sawyer;Alessandro Cozzi-Lepri

  • A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection

    Sabine Kinloch De Loës;Bernard J. Hirschel;Bruno Hoen;David A. Cooper

  • A Patient with HIV-1 Superinfection

    Stephanie Jost;Marie-Charlotte Bernard;Laurent Kaiser;Sabine Yerly

  • Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.

    S Yerly;S Vora;P Rizzardi;J P Chave

  • The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

    Angela Huttner;Julie-Anne Dayer;Sabine Yerly;Christophe Combescure

  • CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1 : results of the staccato randomised trial

    Jintanat Ananworanich;Angèle Gayet-Ageron;Michelle Le Braz;Wisit Prasithsirikul

  • Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

    Patrizio Lorenzi;Milos Opravil;Bernard Hirschel;Jean-Philippe Chave

  • Minority Quasispecies of Drug-Resistant HIV-1 That Lead to Early Therapy Failure in Treatment-Naive and -Adherent Patients

    Karin J. Metzner;Stefano G. Giulieri;Stefanie A. Knoepfel;Pia Rauch

  • Travel and the spread of HIV-1 genetic variants

    Luc Perrin;Laurent Kaiser;Sabine Yerly

  • Estimating the Basic Reproductive Number from Viral Sequence Data

    Tanja Stadler;Roger Kouyos;Viktor von Wyl;Sabine Yerly

  • Chronic Rhinoviral Infection in Lung Transplant Recipients

    Laurent Kaiser;John-David Aubert;Jean-Claude Pache;Christelle Deffernez

  • A prospective trial of structured treatment interruptions in human immunodeficiency virus infection

    Catherine Fagard;Annette Oxenius;Huldrych Günthard;Felipe Garcia

  • Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland.

    Javier Perez-Saez;Stephen A Lauer;Laurent Kaiser;Simon Regard

  • Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users.

    Chamot E;Hirschel B;Wintsch J;Robert Cf

Frequent Co-Authors

Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Thomas Klimkait
Thomas Klimkait University of Basel
Jürg Böni
Jürg Böni University of Zurich
Matthias Cavassini
Matthias Cavassini University of Lausanne
Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Laurent Kaiser
Laurent Kaiser Hôpitaux Universitaires de Genève
Manuel Battegay
Manuel Battegay University Hospital of Basel
Pietro Vernazza
Pietro Vernazza University of St. Gallen
Roger D. Kouyos
Roger D. Kouyos University of Zurich
Alexandra Calmy
Alexandra Calmy University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various related fields, many of which now offer flexible online degree options. For instance, those interested in the health sciences might explore what medical degrees can I get online to find programs that suit their career goals and lifestyle. This approach allows students to balance education with other commitments.

Public health is another complementary area, with several accredited programs available remotely. The list of accredited online MPH programs easy to get into provides options for those seeking to enter the public health sector without high entry barriers.

Career pathways stemming from microbiology include specialized roles like child life specialists, where understanding health and human biology plays a crucial role. Those curious about this profession and its prospects can discover insights on how much does a child life specialist make to weigh potential returns on educational investment.

Importantly, online education also supports non-traditional students. Many programs are designed to be accommodating, including online degrees for felons, enabling individuals with past records to pursue meaningful careers and improve their futures.

Best Scientists Citing Sabine Yerly

Trending Scientists

Recently Published Articles